Marc Humbert, MD, PhD

Articles by Marc Humbert, MD, PhD

High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

ByGiuliana Grossi,Christian Ruff, MD,John Buse, MD, PhD,Marc P. Bonaca, MD, MPH,Marc Humbert, MD, PhD,Jawad Haider Butt, MD, PhD,Siddharth M. Patel, MD, MPH

April 4th 2025

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.

ZENITH Trial Findings Could Reshape PAH Treatment, Extending Sotatercept’s Reach

ByGiuliana Grossi,Marc Humbert, MD, PhD

March 31st 2025

Another study testing sotatercept as an early intervention for pulmonary arterial hypertension (PAH) is anticipated to determine the effect on outcomes, Marc Humbert, MD, PhD, University Paris-Saclay, explains in an interview.

Marc Humbert, MD, PhD

Articles by Marc Humbert, MD, PhD

High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

ZENITH Trial Findings Could Reshape PAH Treatment, Extending Sotatercept’s Reach

Latest Updated Articles

Trending on AJMC

FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH

In Primary Care–Oncology Collaboration, the Baton Goes Both Ways

Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology

FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer

Information and Integration Can Take Oncology Patients From Surviving to Thriving